<p>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to ADHD disease and/or their response to a particular drug or drugs.</p>
申请公布号
EP2118320(A2)
申请公布日期
2009.11.18
申请号
EP20080741998
申请日期
2008.02.06
申请人
GENIZON BIOSCIENCES INC.
发明人
BELOUCHI, ABDELMAJID;RAELSON, JOHN VERNER;PAQUIN, BRUNO;CROTEAU, PASCAL;BRIAND, SANDY;KEBACHE, SEM;BRUAT, VANESSA;VAN EERDEWEGH, PAUL;SEGAL, JONATHAN;LITTLE, RANDALL DAVID;KEITH, TIM;DUBOIS, DANIEL